Health

Results: 829-840 of 8672

Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026

ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer

PR Newswire associated0

A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM

Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Thea announces roadmap aligned with global climate neutrality objectives

PR Newswire associated0

Clario Leads the Way in Responsible Artificial Intelligence with ISO 42001 certification, audited by Schellman

FDA Approval Granted for Commercial Manufacturing at Rezon Bio's Warsaw-Duchnice Facility

PR Newswire associated0

FDA Grants Breakthrough Device Designation to Two Rapid Tests Targeting Critical Drug-Resistant Pathogens

Year-end report 2025: New CEO takes the helm - initiates the next phase of Enzymatica's international expansion

PR Newswire associated0

Skingevity Launches as New UK Medical Aesthetics Clinic Group with Acquisition of Three Leading Practices

BioArctic Interim Report for the period October - December 2025